Cryptococcal Antigen Lateral Flow Assay Test Market size is expected to reach USD 717 Million by the end of 2036, growing at a CAGR of 4% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of the cryptococcal antigen lateral flow assay test was USD 691 Million. The increase can be ascribed to the rising prevalence of cryptococcal infection worldwide as well as the growing demand for accurate and timely diagnostic instruments. An estimated 15% of HIV-related deaths worldwide are attributed to it, with three-quarters of those deaths taking place in sub-Saharan Africa. An estimated 223,100 cases of cryptococcal meningitis lead to 181,000 deaths annually among people living with HIV. Early detection of cryptococcal infection using these tests enables timely treatment and better patient outcomes. Furthermore, lateral flow tests can be used in resource-constrained environments without complex laboratory equipment because they are frequently portable and simple to operate. For example, the flow test for cryptococcal antigen has shown excellent sensitivity and specificity in identifying cryptococcal antigen in serum and cerebrospinal fluid (CSF) samples.
Increased approvals for the cryptococcal antigen lateral flow assay tests are also driving the growth of the market. For instance, a dipstick-test lateral flow assay (Immuno-Mycologics, USA) for the semi-quantitative detection of cryptococcal antigen was authorized by the US Food and Drug Administration (FDA) in 2011. This test has the potential to be more advantageous than conventional techniques due to its quick turnaround time, simplicity of use, and reagent stability at room temperature. The World Health Organization suggests using this assay to check for cryptococcal antigen in HIV-positive individuals.
Growth Drivers
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
~ 4% |
|
Base Year Market Size (2023) |
~ USD 691 Million |
|
Forecast Year Market Size (2036) |
~ USD 717 Million |
|
Regional Scope |
|
Type (Serum-based Lateral Flow Assay Tests, Cerebrospinal Fluid-based Lateral Flow Assay Tests)
Serum-based lateral flow assay tests segment for cryptococcal antigen lateral flow assay test market is expected to hold the largest share of 56% during the foreseen period. Serum-based assays identify particular markers or analytes in the bloodstream, providing useful diagnostic information. Numerous illnesses, such as cancer, autoimmune diseases, hormone abnormalities, and viral infections, can be diagnosed with these tests. Additionally, even at low concentrations, these assays are capable of precisely identifying and measuring target analytes in serum samples. Furthermore, the performance, repeatability, and throughput of serum-based assays have all increased with automation and standardization. To improve laboratory productivity and efficiency, healthcare facilities are progressively implementing automated methods for serum-based testing. Additionally, this test is essential to customized therapy because it helps determine the best course of action for each patient.
Instruments (Lateral Flow Readers, Kits, and Reagents)
The kits and reagents segment for the cryptococcal antigen lateral flow assay test market is anticipated to hold the second-largest share of 53% during the projected period. With the use of these lateral flow kits, users may be more flexible in capturing and identifying any kind of analyte without having to apply the captured antibodies onto the test strip. These kits are utilized in medicines, animal health, environmental testing, feed and food testing, and crop and plant testing because of their versatility. During the projected period, new kit launches by leading manufacturers are expected to stimulate market growth. Also, the growing adoption of self-test kits for COVID-19 and other diseases is accelerating the growth of the segment. For instance, the Kenyan government has introduced two novel technologies, pre-exposure prophylaxis (PrEP) to prevent HIV infection and self-testing for HIV, in the hopes of taking the fight against the AIDS epidemic one step closer. HIV self-test kits are being provided by the government as part of the campaign at a low cost of about USD 8 per kit, which was negotiated in collaboration with the commercial sector and public and private health facilities.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Instruments |
|
|
Location |
|
|
End-user |
|
Middle East and Africa Market Forecast
Cryptococcal antigen lateral flow assay test market in the Middle East and Africa is expected to hold a share of 34% during the forecast period. The high prevalence of HIV/AIDS in the region has led to an increase in the incidence of cryptococcal infections, which in turn has increased demand for diagnostic tests. Inadequate laboratory facilities and a dearth of healthcare workers are two issues that many nations in the region confront as a result of their weak healthcare infrastructure. International organizations are consequently making significant investments in these regions' healthcare infrastructure, which is propelling the market's expansion.
North American Market Statistics
North American cryptococcal antigen lateral flow assay test market is poised to grow majorly with a share of 28% by the end of 2036. The region boasts a firmly established healthcare network, complete with clinical laboratories outfitted with diagnostic testing capabilities. Furthermore, biotechnology companies actively create novel diagnostic tools, and the regional government makes significant investments in research and development. For instance, the amount invested in medical and health research and development (R&D) in the United States (U.S.) in 2020 was USD 245.1 billion, an increase of 11.1% over 2019. Additionally, the market expansion in this region is being supported by the rising need for lateral flow assays that are simple to use in a variety of healthcare settings.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?